Gastrointestinal (GI) cancers are the second leading cause of cancer deaths worldwide amounting to 4.5 million global deaths per year.

According to the American Cancer Society statistics, GI cancers collectively have the highest incidence and account for 20% of estimated new cancer cases.

GI cancers include esophageal, gastric, hepatocellular, pancreatic, small bowel, bile duct, anal, colorectal and gallbladder cancers.

We are discussing novel agents and therapeutic approaches for the treatment of gastrointestinal cancers and how new trial findings might affect treatment of these cancers in the future with GI cancer expert Dr.

Alan P Venook of UCSF Helen Diller Family Comprehensive Cancer Center.